Clinical Trial Update: A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 [Phase 2]

View source ↗

Summary

One-year open-label follow-up study to treat hypogonadism in men who completed ZA-203; the trial is in Phase 2 and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• ZA-203

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Hypogonadism, Low Testosterone | Phase 2 | Status: COMPLETED